Merck & Co., Inc. (MRK)

USD 83.18

(-0.1%)

Net Debt Summary of Merck & Co., Inc.

  • Merck & Co., Inc.'s latest annual net debt in 2023 was 29.35 Billion USD , up 63.13% from previous year.
  • Merck & Co., Inc.'s latest quarterly net debt in 2024 Q2 was 26.44 Billion USD , down -7.38% from previous quarter.
  • Merck & Co., Inc. reported annual net debt of 17.99 Billion USD in 2022, down -28.03% from previous year.
  • Merck & Co., Inc. reported annual net debt of 25 Billion USD in 2021, up 5.38% from previous year.
  • Merck & Co., Inc. reported quarterly net debt of 26.44 Billion USD for 2024 Q2, down -7.38% from previous quarter.
  • Merck & Co., Inc. reported quarterly net debt of 21 Billion USD for 2023 Q1, up 16.73% from previous quarter.

Annual Net Debt Chart of Merck & Co., Inc. (2023 - 1989)

Historical Annual Net Debt of Merck & Co., Inc. (2023 - 1989)

Year Net Debt Net Debt Growth
2023 29.35 Billion USD 63.13%
2022 17.99 Billion USD -28.03%
2021 25 Billion USD 5.38%
2020 23.72 Billion USD 42.35%
2019 16.67 Billion USD -2.79%
2018 17.14 Billion USD -6.38%
2017 18.31 Billion USD -0.05%
2016 18.32 Billion USD 1.87%
2015 17.99 Billion USD 28.85%
2014 13.96 Billion USD 47.92%
2013 9.43 Billion USD 32.61%
2012 7.11 Billion USD 78.66%
2011 3.98 Billion USD -42.94%
2010 6.98 Billion USD -14.25%
2009 8.14 Billion USD 334.95%
2008 1.87 Billion USD 364.2%
2007 403.3 Million USD -56.23%
2006 921.4 Million USD 161.93%
2005 -1.48 Billion USD -137.25%
2004 3.99 Billion USD -28.62%
2003 5.59 Billion USD -11.27%
2002 6.3 Billion USD -6.18%
2001 6.72 Billion USD 53.34%
2000 4.38 Billion USD 10.1%
1999 3.98 Billion USD 221.36%
1998 1.23 Billion USD 10.22%
1997 1.12 Billion USD 174.39%
1996 409.6 Million USD 895.34%
1995 -51.5 Million USD 83.46%
1994 -311.4 Million USD -115.36%
1993 2.02 Billion USD 171.84%
1992 745.8 Million USD 2080.7%
1991 34.2 Million USD -69.11%
1990 110.7 Million USD 146.13%
1989 -240 Million USD 74.69%

Peer Net Debt Comparison of Merck & Co., Inc.

Name Net Debt Net Debt Difference
AbbVie Inc. 46.57 Billion USD 36.959%
Bristol-Myers Squibb Company 30 Billion USD 2.137%
Bristol-Myers Squibb Company Ce 30 Billion USD 2.137%
Johnson & Johnson 7.47 Billion USD -292.868%
Eli Lilly and Company 22.4 Billion USD -31.028%
Novartis AG 12.95 Billion USD -126.623%
Organon & Co. 8.06 Billion USD -263.94%
Pfizer Inc. 72.18 Billion USD 59.33%